| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory conditions. Leveraging a proprietary technology pl..
>Volltext.. |
| 1620.6 Mio. EUR |
| 1625.01 Mio. EUR |
| 58.13 Mio. EUR |
| -57.99 Mio. EUR |
| -84.89 Mio. EUR |
| -0.07 EUR |
| 117.24 Mio. EUR |
| 112.75 Mio. EUR |
| - |
| 1.01 |
| 1011.51% |
| 10.99% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 10.06.26 |
|